Mapi Pharma mapi-pharma.com


Public lists: Pharma Startups (4733)

Mapi Pharma is a development stage pharmaceutical company, engaged in the development of high-barrier to entry and high-added value life cycle management ("LCM") products that target large markets and generic drugs that include complex active pharmaceutical ingredients ("APIs") and formulations. The GA Depot once every four weeks injection is the first in a series of depot long-acting injections in the company's pipeline for the treatment of MS an LCM of Copaxone, which requires daily or every s...Show all

Mapi Pharma is a development stage pharmaceutical company, engaged in the development of high-barrier to entry and high-added value life cycle management ("LCM") products that target large markets and generic drugs that include complex active pharmac...Show all

Company (Alive / Active)

Phone: +972-73-2723750

Fax:

Weizmann Science Park
16 Einstein St.
Ness Ziona, 74140
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mapi Pharma $20M Apr 27, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mapi Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Intermediate compounds and process for the preparation of efinaconazole Mar 02, 2015 Apr 11, 2017 Patent
Polymorphs of darunavir Nov 24, 2014 Sep 27, 2016 Patent
Amorphous form of dolutegravir Sep 02, 2012 Dec 08, 2015 Patent
Random pentapolymer for treatment of autoimmune diseases Feb 11, 2013 Dec 01, 2015 Patent
Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium Aug 28, 2014 Aug 11, 2015 Patent
See all 21 patents